Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure

心力衰竭的心脏谱系特异性分子机制

基本信息

  • 批准号:
    10558570
  • 负责人:
  • 金额:
    $ 76.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-02-01 至 2025-01-31
  • 项目状态:
    未结题

项目摘要

Project Summary The heart consists of a multitude of diverse cardiac cell types, including but not limited to cardiomyocytes, cardiac fibroblasts, epicardial cells, endothelial/endocardial cells and smooth muscle cells, which coordinate to sustain cardiac function and circulation throughout the body. Thus, regulated maintenance of these cell types is crucial for optimal heart performance and disrupting the function of specific cell lineages can result in distinct heart diseases including heart failure, which is a major leading cause of morbidity and mortality worldwide. However, what are the specific cell lineages affected during heart failure and how do gene regulatory networks control genetic programs that direct their pathologic outcomes are key biomedical questions that remain to be resolved. To address these issues, we have created an interdisciplinary team that includes physician-scientists who will collect patient heart tissue samples to investigate molecular mechanisms involved in the pathogenesis of heart failure; genomic and epigenomic experts who will employ cutting-edge single-cell sequencing and chromatin analysis technologies to examine cell-type specific chromatin accessibility-interactions and corresponding gene expression; and stem cell biologists who will utilize human pluripotent stem cell cardiac models and state-of-the-art genome-editing strategies to perform functional confirmation studies. Through these integrative efforts and analyses, we plan to examine the hypothesis that cis-regulatory elements and their enhancer-promoter interactions dynamically function and coordinate in a cell- type specific manner to direct lineage-specific gene expression during cardiac tissue homeostasis, and altering these highly-regulated cell-type specific cis-regulatory elements and corresponding gene regulatory networks can lead to heart failure. Specifically, we propose to 1) identify cis-regulatory elements and cell-types that are affected by heart failure-associated non-coding genetic variants; 2) investigate how gene regulatory networks controlling specific cardiovascular cell-types are altered during heart failure; and 3) examine how perturbations of cell-type specific cis-regulatory elements and gene regulatory networks during heart failure impact cell function and gene expression.
项目摘要 心脏由多种不同的心脏细胞类型组成,包括但不限于心肌细胞, 心脏成纤维细胞、心外膜细胞、内皮/内皮细胞和平滑肌细胞,它们协调 维持心脏功能和整个身体的循环。因此,这些细胞类型的调节维持 是最佳心脏性能的关键,破坏特定细胞谱系的功能可导致不同的心脏功能。 心脏病,包括心力衰竭,这是发病率和死亡率的主要主要原因 国际吧然而,在心力衰竭过程中,哪些特定的细胞谱系受到影响,基因是如何影响的? 调控网络控制遗传程序,指导其病理结果是关键的生物医学 仍有待解决的问题。为了解决这些问题,我们成立了一个跨学科团队, 包括收集患者心脏组织样本以研究分子机制的医生科学家 参与心力衰竭的发病机制;基因组和表观基因组专家谁将聘请尖端 单细胞测序和染色质分析技术,以检查细胞类型特异性染色质 可及性相互作用和相应的基因表达;和干细胞生物学家谁将利用人类 多能干细胞心脏模型和最先进的基因组编辑策略, 确认研究。通过这些综合努力和分析,我们计划检验以下假设: 顺式调节元件及其增强子-启动子相互作用在细胞中动态地起作用和协调, 型特异性的方式来指导谱系特异性基因表达在心脏组织稳态,并改变 这些高度调控的细胞类型特异性顺式调控元件和相应的基因调控网络 会导致心力衰竭具体来说,我们建议1)确定顺式调节元件和细胞类型, 受心力衰竭相关的非编码遗传变异的影响; 2)研究基因调控网络如何 控制特定的心血管细胞类型在心力衰竭期间改变;和3)检查扰动如何 心力衰竭过程中细胞类型特异性顺式调控元件和基因调控网络对细胞的影响 功能和基因表达。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Neil C Chi其他文献

Coordinating the first heartbeat
协调第一次心跳
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    64.8
  • 作者:
    Joshua Bloomekatz;Neil C Chi
  • 通讯作者:
    Neil C Chi

Neil C Chi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Neil C Chi', 18)}}的其他基金

Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)
HIV 感染中新的克隆造血作用不确定性、镶嵌染色体改变和心血管疾病的评估(HIV 中的 ENCODE CVD)
  • 批准号:
    10753791
  • 财政年份:
    2023
  • 资助金额:
    $ 76.63万
  • 项目类别:
Cell-Type Specific Mechanisms of HIV Cardiomyopathy
HIV心肌病的细胞类型特异性机制
  • 批准号:
    10534777
  • 财政年份:
    2021
  • 资助金额:
    $ 76.63万
  • 项目类别:
Cell-Type Specific Mechanisms of HIV Cardiomyopathy
HIV心肌病的细胞类型特异性机制
  • 批准号:
    10413721
  • 财政年份:
    2021
  • 资助金额:
    $ 76.63万
  • 项目类别:
Genetic regulation of cardiac inflow tract formation in zebrafish
斑马鱼心脏流入道形成的遗传调控
  • 批准号:
    10405548
  • 财政年份:
    2021
  • 资助金额:
    $ 76.63万
  • 项目类别:
Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure
心力衰竭的心脏谱系特异性分子机制
  • 批准号:
    10152319
  • 财政年份:
    2021
  • 资助金额:
    $ 76.63万
  • 项目类别:
Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure
心力衰竭的心脏谱系特异性分子机制
  • 批准号:
    10852685
  • 财政年份:
    2021
  • 资助金额:
    $ 76.63万
  • 项目类别:
Cardiac Lineage-Specific Molecular Mechanisms of Heart Failure
心力衰竭的心脏谱系特异性分子机制
  • 批准号:
    10337287
  • 财政年份:
    2021
  • 资助金额:
    $ 76.63万
  • 项目类别:
Genetic regulation of cardiac inflow tract formation in zebrafish
斑马鱼心脏流入道形成的遗传调控
  • 批准号:
    10621218
  • 财政年份:
    2021
  • 资助金额:
    $ 76.63万
  • 项目类别:
Mechanisms of Posterior Heart Field Development
心后区发育机制
  • 批准号:
    10669667
  • 财政年份:
    2020
  • 资助金额:
    $ 76.63万
  • 项目类别:
Fine-scale Spatiotemporal Mapping of Cellular Regulatory Networks Directing Heart Development
指导心脏发育的细胞调节网络的精细时空绘图
  • 批准号:
    10223399
  • 财政年份:
    2020
  • 资助金额:
    $ 76.63万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 76.63万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 76.63万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.63万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.63万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 76.63万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.63万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 76.63万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 76.63万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 76.63万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 76.63万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了